Your browser doesn't support javascript.
loading
Efficacy of an Anti-Semaphorin 3A Neutralizing Antibody in a Male Experimental Retinal Vein Occlusion Mouse Model.
Nakamura, Shinsuke; Nishinaka, Anri; Hidaka, Yae; Shimazawa, Masamitsu; Thomas, Leo; Bakker, Remko A; Hara, Hideaki.
Affiliation
  • Nakamura S; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.
  • Nishinaka A; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.
  • Hidaka Y; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.
  • Shimazawa M; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.
  • Thomas L; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach and der Riß, Germany.
  • Bakker RA; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach and der Riß, Germany.
  • Hara H; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.
Invest Ophthalmol Vis Sci ; 63(8): 14, 2022 07 08.
Article in En | MEDLINE | ID: mdl-35822950
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retinal Diseases / Retinal Vein Occlusion / Macular Edema Type of study: Prognostic_studies Limits: Animals Language: En Journal: Invest Ophthalmol Vis Sci Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retinal Diseases / Retinal Vein Occlusion / Macular Edema Type of study: Prognostic_studies Limits: Animals Language: En Journal: Invest Ophthalmol Vis Sci Year: 2022 Document type: Article Affiliation country: Country of publication: